Companies / Czech Republic
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Turkey Drives Sales Growth For Zentiva
July 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Czech generics specialist Zentiva has said it expects sales to reach CZK8.9bn for the first half of 2008, a 32% year-on-year (y-o-y) growth. A continuing decline in sales in its key markets of Czech Republic and Romania was buffered by inclusion of sales from Eczacibaşi, the Turkish firm acquired by Zentiva in